Business

Anti-diabetes drug Vildagliptin to become 80% cheaper

Anti-diabetes drug Vildagliptin to become 80% cheaper The patents for Vildagliptin in India held by Novartis were expired on December 9, opening the market for cheap rip-offs.

from Moneycontrol Business News
Read The Rest:moneycontrol...

Realted Posts